Send us Fan MailSSRI Switching in Pediatrics: When to Try a Third SSRI, When to Use Luvox, and Key Metabolism PearlsDr. Elise Fallucco continues her discussion with child psychiatrist Dr. Jeffrey Strawn (University of Cincinnati; co-author of Stahl’s DePrescribing) on practical tips regarding how to stop/decrease an SSRI and switch to another SSRI (or SNRI) for pediatric anxiety. Highlights from the Episode:After trying 2 different SSRIs for pediatric anxiety, in most cases, it makes sense to try a third SSRI as opposed to an SNRIRationale: SSRIs tend to be more effective and have fewer side effects than SNRIs"We Don't Talk about LUVOX": Luvox can be a great option for youth with OCD OR anxiety (generalized, social, separation)Dosing strategy: start at 25mg with the plan to titrate up to a target dose of 150-200mgConsider grouping 3 of the SSRIs by their similar metabolic pathways (2C19): Sertraline, Citalopram, and EscitalopramIf your patient develops significant side effects on a low dose of one of these 3 meds, they MIGHT be a 2C19 poor metabolizer, which means that you may want to avoid trials of the other 2C19 meds in the groupFluoxetine has a LOOOOONg half-life: and it's related 2D6 inhibition will persist 4–5 weeks after stopping Fluoxetine - and affect the metabolism of other 2D6-metabolized meds during that timeThe 2D6 group includes meds like Fluoxetine, Paroxetine and 2 of the SNRIs: Duloxetine and Venlafaxine00:00 Introduction of Dr. Jeffrey Strawn00:38 Preview of Episode: Switching SSRIs, when to use FluVOXamine or SNRIs, plus 2D6 and 2C19 metabolism of antidepressant medication01:59 Try 2 different SSRIs or Duloxetine?03:45 CYP 2D6 Inhibition with Fluoxetine04:28 Clinical Pearl: Fluoxetine 2D6 inhibition continues 4-5 weeks after stopping05:05 2D6 Metabolized Antidepressants: Venlafaxine, Duloxetine, Paroxetine05:31 Choosing a Third SSRI05:48 SSRIs generally more effective, fewer side effects than SRNIs in youth06:49 Only 1 SNRI for child anxiety07:27 People forget about Fluvoxamine08:30 Sertraline and Es/Citalopram 2C19 metabolism09:32 Fluoxetine to FluVOXamine cross-titration11:16 Gratitude for Dr. Strawn11:31 Check out Stahl's DEPrescribing Guide12:23 Recap of Advanced SSRI and SNRI case discussion Check out our website PsychEd4Peds.com for more resources.Follow us on Instagram @psyched4peds

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related